stella
beta
Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients — Stella
Recruiting
Back to HER2-positive Early Breast Cancer trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Peking University People'S Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov